Operative Re-Intervention following Pancreatoduodenectomy: What Has Changed over the Last Decades
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
References
- Krautz, C.; Nimptsch, U.; Weber, G.F.; Mansky, T.; Grützmann, R. Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany. Ann. Surg. 2018, 267, 411–417. [Google Scholar] [CrossRef] [PubMed]
- Gleeson, E.M.; Shaikh, M.F.; Shewokis, P.A.; Clarke, J.R.; Meyers, W.C.; Pitt, H.A.; Bowne, W.B. WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database. Surgery 2016, 160, 1279–1287. [Google Scholar] [CrossRef] [PubMed]
- Wente, M.N.; Bassi, C.; Dervenis, C.; Fingerhut, A.; Gouma, D.J.; Izbicki, J.R.; Neoptolemos, J.P.; Padbury, R.T.; Sarr, M.G.; Traverso, L.W.; et al. Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007, 142, 761–768. [Google Scholar] [CrossRef] [PubMed]
- Wente, M.N.; Veit, J.A.; Bassi, C.; Dervenis, C.; Fingerhut, A.; Gouma, D.J.; Izbicki, J.R.; Neoptolemos, J.P.; Padbury, R.T.; Sarr, M.G.; et al. Postpancreatectomy hemorrhage (PPH): An International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007, 142, 20–25. [Google Scholar] [CrossRef]
- Bassi, C.; Marchegiani, G.; Dervenis, C.; Sarr, M.; Abu Hilal, M.; Adham, M.; Allen, P.; Andersson, R.; Asbun, H.J.; Besselink, M.G.; et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017, 161, 584–591. [Google Scholar] [CrossRef]
- Karim, S.A.M.; Abdulla, K.S.; Abdulkarim, Q.H.; Rahim, F.H. The outcomes and complications of pancreaticoduodenectomy (Whipple procedure): Cross sectional study. Int. J. Surg. 2018, 52, 383–387. [Google Scholar] [CrossRef]
- Standop, J.; Glowka, T.; Schmitz, V.; Schäfer, N.; Overhaus, M.; Hirner, A.; Kalff, J.C. Operative re-intervention following pancreatic head resection: Indications and outcome. J. Gastrointest. Surg. 2009, 13, 1503–1509. [Google Scholar] [CrossRef]
- Reddy, J.R.; Saxena, R.; Singh, R.K.; Pottakkat, B.; Prakash, A.; Behari, A.; Gupta, A.K.; Kapoor, V.K. Reoperation following Pancreaticoduodenectomy. Int. J. Surg. Oncol. 2012, 2012, 218248. [Google Scholar] [CrossRef]
- Lyu, H.G.; Sharma, G.; Brovman, E.; Ejiofor, J.; Repaka, A.; Urman, R.D.; Gold, J.S.; Whang, E.E. Risk Factors of Reoperation After Pancreatic Resection. Dig. Dis. Sci. 2017, 62, 1666–1675. [Google Scholar] [CrossRef]
- Qiu, H.; Shan, R.-F.; Ai, J.-H.; Ye, S.P.; Shi, J. Risk factors for 30-day unplanned reoperation after pancreatoduodenectomy: A single-center experience. J. Cancer. Res. Ther. 2011, 5, 1530–1534. [Google Scholar]
- Lessing, Y.; Pencovich, N.; Nevo, N.; Lubezky, N.; Goykhman, Y.; Nakache, R.; Lahat, G.; Klausner, J.M.; Nachmany, I. Early reoperation following pancreaticoduodenectomy: Impact on morbidity, mortality, and long-term survival. World J. Surg. Oncol. 2019, 17, 26. [Google Scholar] [CrossRef] [PubMed]
- Dindo, D.; Demartines, N.; Clavien, P.-A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef] [PubMed]
- Hafke, J.; van Beekum, C.; Manekeller, S.; Vilz, T.O.; Kalff, J.C.; Glowka, T.R. The Impact of Supra- and Infracolic Reconstruction on Delayed Gastric Emptying Following Pancreatoduodenectomy. Zentralbl. Chir. 2020, 145, 27–34. [Google Scholar] [PubMed]
- Standop, J.; Overhaus, M.; Schaefer, N.; Decker, D.; Wolff, M.; Hirner, A.; Tuerler, A. Pancreatogastrostomy after pancreatoduodenectomy: A safe, feasible reconstruction method? World J. Surg. 2005, 29, 505–512. [Google Scholar] [CrossRef] [PubMed]
- Glowka, T.R.; Webler, M.; Matthaei, H.; Schäfer, N.; Schmitz, V.; Kalff, J.C.; Standop, J.; Manekeller, S. Delayed gastric emptying following pancreatoduodenectomy with alimentary reconstruction according to Roux-en-Y or Billroth-II. BMC Surg. 2017, 17, 24. [Google Scholar] [CrossRef]
- Standop, J.; Glowka, T.; Schmitz, V.; Schaefer, N.; Hirner, A.; Kalff, J.C. Emergency Kausch-Whipple procedure: Indications and experiences. Pancreas 2010, 39, 156–159. [Google Scholar] [CrossRef]
- Cheng, Z.; Johar, A.; Gottlieb-Vedi, E.; Nilsson, M.; Lagergren, J.; Lagergren, P. Impact of co-morbidity on reoperation or death within 90 days of surgery for oesophageal cancer. BJS Open 2021, 5, zraa035. [Google Scholar] [CrossRef]
- Scheufele, F.; Schorn, S.; Demir, I.E.; Sargut, M.; Tieftrunk, E.; Calavrezos, L.; Jäger, C.; Friess, H.; Ceyhan, G.O. Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: A meta-analysis of current literature. Surgery 2017, 161, 939–950. [Google Scholar] [CrossRef]
- Darnell, E.P.; Wang, T.J.; Lumish, M.A.; Hernandez-Barco, Y.G.; Weniger, M.; Casey, B.W.; Qadan, M.; Lillemoe, K.D.; Ferrone, C.R.; Fernandez-Del Castillo, C.; et al. Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer. Am. J. Surg. 2021, 221, 134–140. [Google Scholar] [CrossRef]
- Maggino, L.; Liu, J.B.; Ecker, B.L.; Pitt, H.A.; Vollmer, C.M., Jr. Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database. J. Am. Coll. Surg. 2018, 226, 844–857. [Google Scholar] [CrossRef]
- Seykora, T.F.; Ecker, B.L.; McMillan, M.T.; Maggino, L.; Beane, J.D.; Fong, Z.V.; Hollis, R.H.; Jamieson, N.B.; Javed, A.A.; Kowalsky, S.J.; et al. The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy. Ann. Sur. 2019, 270, 147–157. [Google Scholar] [CrossRef] [PubMed]
- Casciani, F.; Trudeau, M.T.; Asbun, H.J.; Ball, C.G.; Bassi, C.; Behrman, S.W.; Berger, A.C.; Bloomston, M.P.; Callery, M.P.; Christein, J.D.; et al. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. Surgery 2021, 170, 1195–1204. [Google Scholar] [CrossRef] [PubMed]
- Smits, F.J.; van Santvoort, H.C.; Besselink, M.G.; Batenburg, M.C.T.; Slooff, R.A.E.; Boerma, D.; Busch, O.R.; Coene, P.P.L.O.; van Dam, R.M.; van Dijk, D.P.J.; et al. Management of Severe Pancreatic Fistula After Pancreatoduodenectomy. JAMA Surg. 2017, 152, 540–548. [Google Scholar] [CrossRef] [PubMed]
- Callery, M.P.; Pratt, W.B.; Kent, T.S.; Chaikof, E.L.; Vollmer, C.M., Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J. Am. Coll. Surg. 2013, 216, 1–14. [Google Scholar] [CrossRef]
- Mungroop, T.H.; van Rijssen, L.B.; van Klaveren, D.; Smits, F.J.; van Woerden, V.; Linnemann, R.J.; de Pastena, M.; Klompmaker, S.; Marchegiani, G.; Ecker, B.L.; et al. Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation. Ann. Surg. 2019, 269, 937–943. [Google Scholar] [CrossRef]
- Mungroop, T.H.; Klompmaker, S.; Wellner, U.F.; Steyerberg, E.W.; Coratti, A.; D’Hondt, M.; de Pastena, M.; Dokmak, S.; Khatkov, I.; Saint-Marc, O.; et al. Updated Alternative Fistula Risk Score (ua-FRS) to Include Minimally Invasive Pancreatoduodenectomy: Pan-European Validation. Ann. Surg. 2021, 273, 334–340. [Google Scholar] [CrossRef]
- Grendar, J.; Jutric, Z.; Leal, J.N.; Ball, C.G.; Bertens, K.; Dixon, E.; Hammill, C.W.; Kastenberg, Z.; Newell, P.H.; Rocha, F.; et al. Validation of Fistula Risk Score calculator in diverse North American HPB practices. HPB 2017, 19, 508–514. [Google Scholar] [CrossRef]
- Keck, T.; Wellner, U.F.; Bahra, M.; Klein, F.; Sick, O.; Niedergethmann, M.; Wilhelm, T.J.; Farkas, S.A.; Börner, T.; Bruns, C.; et al. Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial. Ann. Surg. 2016, 263, 440–449. [Google Scholar] [CrossRef]
- Sanjay, P.; Kellner, M.; Tait, I.S. The role of interventional radiology in the management of surgical complications after pancreatoduodenectomy. HPB 2012, 14, 812–817. [Google Scholar] [CrossRef]
- Van Floortje Oosten, A.; Smits, F.J.; van den Heuvel, D.A.F.; van Santvoort, H.C.; Molenaar, I.Q. Diagnosis and management of postpancreatectomy hemorrhage: A systematic review and meta-analysis. HPB 2019, 21, 953–961. [Google Scholar] [CrossRef]
- Huang, Y.; Damodaran Prabha, R.; Chua, T.C.; Arena, J.; Kotecha, K.; Mittal, A.; Gill, A.J.; Samra, J.S. Safety and Efficacy of Pancreaticoduodenectomy in Octogenarians. Front. Surg. 2021, 8, 617286. [Google Scholar] [CrossRef] [PubMed]
- Kisch, S.E.; Nussbaum, E.R.; Varsanik, M.A.; O’Hara, A.; Pozin, J.J.; Littau, M.J.; Wang, X.; Carollo, E.; Knab, L.M.; Abood, G. Octogenarians undergoing pancreaticoduodenectomy: Assessing outcomes, disposition, and timing of chemotherapy. Surg. Open Sci. 2022, 7, 58–61. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.Y.; Weinberg, L.; Christophi, C.; Nikfarjam, M. The outcomes of pancreaticoduodenectomy in patients aged 80 or older: A systematic review and meta-analysis. HPB 2017, 19, 475–482. [Google Scholar] [CrossRef] [PubMed]
- Isaji, S.; Mizuno, S.; Windsor, J.A.; Bassi, C.; Fernández-Del Castillo, C.; Hackert, T.; Hayasaki, A.; Katz, M.H.G.; Kim, S.W.; Kishiwada, M.; et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 2018, 18, 2–11. [Google Scholar] [CrossRef]
- Valgimigli, M.; Bueno, H.; Byrne, R.A.; Collet, J.P.; Costa, F.; Jeppsson, A.; Jüni, P.; Kastrati, A.; Kolh, P.; Mauri, L.; et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2018, 39, 213–260. [Google Scholar]
- Kaczmarek, D.J.; Heling, D.J.; Gonzalez-Carmona, M.A.; Strassburg, C.P.; Branchi, V.; Matthaei, H.; Kalff, J.; Manekeller, S.; Glowka, T.R.; Weismüller, T.J. Management of post-operative pancreatic fistulas following Longmire-Traverso pylorus-preserving pancreatoduodenectomy by endoscopic vacuum-assisted closure therapy. BMC Gastroenterol. 2021, 21, 425. [Google Scholar] [CrossRef]
Operative re-Intervention | No Operative Re-Intervention | p | |
---|---|---|---|
n = 81 | n = 328 | ||
age (a) | 67 (58–73) | 66 (57–75) | 0.956 |
age >80 years | 4 (5%) | 33 (10%) | 0.150 |
gender female | 24 (30%) | 136 (41%) | 0.051 |
BMI (kg/m2) | 25.1 (22.3–28.7) | 24.8 (22.5–27.7) | 0.695 |
diagnosis malignant | 58 (72%) | 249 (76%) | 0.422 |
alcohol abuse | 27 (33%) | 93 (28%) | 0.273 |
nicotine (active consumption) | 21 (26%) | 98 (30%) | 0.543 |
weight loss | 36 (43%) | 174 (50%) | 0.117 |
Charlson Comorbidity Index | 2 (1–3) | 2 (2–3) | 0.046 |
preoperative cholangitis | 30 (30%) | 53 (16%) | 0.005 |
preoperative biliary drainage | 34 (42%) | 166 (51%) | 0.193 |
previous operations | 28 (35%) | 142 (43%) | 0.884 |
Operative Re-Intervention | No Operative Re-Intervention | p | |
---|---|---|---|
n = 81 | n = 328 | ||
duration of operation (min) | 458 (355–556) | 401 (333–473) | 0.003 |
blood loss (mL) | 800 (475–1500) | 600 (375–1000) | 0.036 |
transfusions (erythrocyte concentrate) | 1 (0–4) | 0 (0–2) | 0.001 |
positive intraoperative microbiology | 21 (26%) | 149 (45%) | 0.075 |
tumor size (cm) | 3.0 (2.0–4.0) | 2.8 (2.0–3.8) | 0.488 |
soft pancreas parenchyma | 26 (32%) | 96 (29%) | 0.069 |
pancreatic duct >5 mm | 9 (11%) | 48 (15%) | 0.815 |
extended lymphadenectomy | 47 (58%) | 211 (64%) | 0.423 |
resected lymph nodes | 25 (17–31) | 22 (16–30) | 0.199 |
venous reconstruction | 13 (16%) | 54 (16%) | 0.920 |
Operative Re-Intervention | No Operative Re-Intervention | p | |
---|---|---|---|
n = 81 | n = 328 | ||
Clavien major (grade III-IV) | 75 (93%) | 126 (38%) | <0.001 |
insufficiency of BDA | 14 (17%) | 11 (3%) | <0.001 |
insufficiency of DE | 28 (35%) | 4 (1%) | <0.001 |
wound infection (suprafascial) | 39 (48%) | 53 (16%) | <0.001 |
intraabdominal abscess formation | 25 (31%) | 35 (11%) | <0.001 |
PF grade B/C | 36 (44%) | 45 (14%) | <0.001 |
PPH grade B/C | 30 (37%) | 71 (22%) | 0.002 |
DGE grade B/C | 24 (30%) | 63 (19%) | 0.002 |
postoperative stay (d) | 38 (22–64) | 20 (15–26) | <0.001 |
stay in intensive care unit (d) | 6 (2–16) | 2 (1–3) | <0.001 |
stay in intensive care unit with respirator (d) | 1 (0–7) | 0 (0) | <0.001 |
mortality | 20 (25%) | 7 (2%) | <0.001 |
Odds Ratio | 95%-CI | p | |
---|---|---|---|
univariate | |||
reoperation | 15.035 | 6.093–37.099 | ≤0.001 |
PF grade B/C | 3.045 | 1.354–6.846 | 0.005 |
PPH grade B/C | 3.615 | 1.637–7.980 | ≤0.001 |
intraabdominal abscess formation | 2.226 | 0.909–5.652 | 0.072 |
positive intraoperative microbiology | 0.393 | 0.154–1.001 | 0.044 |
multivariate | |||
reoperation | 15.394 | 5.794–40.897 | ≤0.001 |
1989–2007 | 2008–2021 ISGPS | p | |
---|---|---|---|
n = 285 | n = 409 | ||
age > 80 years | 9 (3%) | 37 (9%) | 0.002 |
gender female | 119 (42%) | 160 (39%) | 0.486 |
tumor size (cm) | 2.65 (2.0–3.5) | 2.90 (2.0–3.9) | 0.436 |
duration of operation (min) | 400 (341–461) | 410 (335–460) | 0.572 |
blood loss (mL) | 800 (400–1300) | 600 (400–1000) | 0.075 |
transfusions (erythrocyte concentrate) | 2 (0–4) | 0 (0–2) | <0.001 |
PF yes/no | 42 (15%) | 160 (39%) | <0.001 |
PPH yes/no | 31 (11%) | 115 (28%) | <0.001 |
DGE yes/no | 79 (28%) | 176 (43%) | <0.001 |
reoperation | 31 (11%) | 81 (20%) | 0.002 |
postoperative stay (d) | 17 (14–25) | 21 (15–30) | <0.001 |
stay in intensive care unit (d) | 3 (1–4) | 2 (1–4) | 0.042 |
mortality | 14 (5%) | 27 (6%) | 0.353 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Enderes, J.; Pillny, C.; Standop, J.; Manekeller, S.; Kalff, J.C.; Glowka, T.R. Operative Re-Intervention following Pancreatoduodenectomy: What Has Changed over the Last Decades. J. Clin. Med. 2022, 11, 7512. https://doi.org/10.3390/jcm11247512
Enderes J, Pillny C, Standop J, Manekeller S, Kalff JC, Glowka TR. Operative Re-Intervention following Pancreatoduodenectomy: What Has Changed over the Last Decades. Journal of Clinical Medicine. 2022; 11(24):7512. https://doi.org/10.3390/jcm11247512
Chicago/Turabian StyleEnderes, Jana, Christiane Pillny, Jens Standop, Steffen Manekeller, Jörg C. Kalff, and Tim R. Glowka. 2022. "Operative Re-Intervention following Pancreatoduodenectomy: What Has Changed over the Last Decades" Journal of Clinical Medicine 11, no. 24: 7512. https://doi.org/10.3390/jcm11247512
APA StyleEnderes, J., Pillny, C., Standop, J., Manekeller, S., Kalff, J. C., & Glowka, T. R. (2022). Operative Re-Intervention following Pancreatoduodenectomy: What Has Changed over the Last Decades. Journal of Clinical Medicine, 11(24), 7512. https://doi.org/10.3390/jcm11247512